Ross Berry posts affirmations and bipartisan congratulations on Twitter

Ross Berry, New Hampshire State Representative for Hillsborough 44th District - Facebook
Ross Berry, New Hampshire State Representative for Hillsborough 44th District - Facebook
0Comments

Ross Berry, a public figure active on social media, posted several statements on his Twitter account between January 21 and January 22, 2026. The tweets addressed various topics, including a firm stance on commitments and recognition of a colleague’s achievement.

On January 21, Berry posted “Suck it up, buttercup”. Later that day, he followed with another message: “A deal is a deal. Proud to stand by it.” On January 22, Berry offered congratulations to a fellow political figure: “Moment of serious non-partisan congrats to my colleague @HeathHowardNH for pulling into 2nd.”

Berry’s comments come at a time when political discourse often includes direct language and public affirmations of bipartisan respect. His acknowledgment of Heath Howard’s performance highlights cross-party recognition in the current political environment.



Related

Kristin Noble, New Hampshire Representative for Hillsborough 2nd District

Kristin Noble shares Mother’s Day greeting and celebratory posts on Twitter

Kristin Noble, New Hampshire State Representative, posted Mother’s Day wishes and celebratory emojis to her Twitter followers between May 10 and May 12, 2026.

Ross Berry, New Hampshire State Representative for Hillsborough 44th District - Facebook

Ross Berry discusses local budgets and state spending in recent social media posts

Ross Berry posted several tweets on May 12, 2026 addressing financial topics including personal anecdotes and comparative analysis of state versus local budgets in New Hampshire.

Caleb Michaud, Acting Associate Commissioner for External Affairs of FDA

4 companies in cities within Hillsborough County received four inspections in Q1

There were four companies in cities associated with Hillsborough County that received four FDA inspections in the first quarter of 2026, according to the U.S. Food and Drug Administration.